Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial. uri icon

authors

  • Ray, Kausik K
  • Hanotin, Corinne
  • Harrington, Robert A
  • Jukema, J Wouter
  • Loizeau, Virginie
  • Lopes, Renato D
  • Moryusef, Angèle
  • Murin, Jan
  • Pordy, Robert
  • Ristic, Arsen D
  • Roe, Matthew T
  • Colhoun, Helen M
  • Tuñón, José
  • White, Harvey D
  • Zeiher, Andreas M
  • Schwartz, Gregory G
  • Steg, Philippe Gabriel
  • Szarek, Michael
  • Baccara-Dinet, Marie
  • Bhatt, Deepak L
  • Bittner, Vera A
  • Budaj, Andrzej J
  • Diaz, Rafael
  • Goodman, Shaun G

publication date

  • January 1, 2019